Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2007 ◽
Vol 43
(2)
◽
pp. 308-315
◽
2014 ◽
Vol 50
(2)
◽
pp. 388-396
◽